
Retatrutide — 10 mg
An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg
Materials investigated in controlled metabolic, energetic and mitochondrial models. Nothing in this category constitutes a therapeutic indication or a recommendation for personal use.

An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg

A 20 mg configuration of the investigational peptide analogue studied in multi-receptor models.
20 mg

A mitochondrial-derived peptide used in research on energy signalling and cellular responses.
10 mg

A research coenzyme involved in redox reactions and cellular metabolism. It is classified separately from peptides.
500 mg

A 1,000 mg configuration of the NAD+ coenzyme, intended solely for documented laboratory use.
1,000 mg

A research tetrapeptide associated with preclinical studies of mitochondrial membranes and oxidative stress.
10 mg

A synthetic growth-hormone-releasing hormone analogue listed as a research material with legal status under review.
10 mg

A synthetic fragment corresponding to a region of the human growth hormone sequence; identity must be confirmed by batch documentation.
5 mg
Scientific context for Retatrutide, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for MOTS-c, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for NAD+, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for SS-31 (Elamipretide), evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for Tesamorelin, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for HGH Fragment 176–191, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.